Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 748 of 6351
-
New drug aims to boost immune cells in rare blood disorder
Disease control Recruiting nowThe purpose of this study is to demonstrate the efficacy and evaluate the safety and tolerability of mavorixafor in participants with congenital or acquired primary autoimmune and idiopathic chronic neutropenic disorders who are experiencing recurrent and/or serious infections as…
Phase 3 • Sponsor: X4 Pharmaceuticals • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New combo therapy shows promise for tough esophageal cancer
Disease control Recruiting nowThis study was a single-center, single-arm, open-label phase II clinical trial. Thirty patients with unresectable locally advanced or postoperative recurrent esophageal squamous cell carcinoma were treated with concurrent chemoradiotherapy combined with immunotherapy. The radioth…
Phase 2 • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Can a 10-Hour eating window stabilize mood in bipolar disorder?
Disease control Recruiting nowThe goal of this clinical trial is to compare the effects of two different healthy lifestyles on outcomes for those with bipolar disorder. The goals are to understand the acceptability of time-restricted eating and the mediterranean diet for those who are already receiving medica…
Sponsor: University of California, Berkeley • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
New transplant approach aims to tame bone marrow failure
Disease control Recruiting nowA phase II trial of a reduced intensity conditioned (RIC) allogeneic hematopoietic cell transplant (HCT) with post-transplant cyclophosphamide (PTCy) for idiopathic severe aplastic anemia (SAA), paroxysmal nocturnal hemoglobinuria (PNH), acquired pure red cell aplasia (aPRCA), or…
Phase 2 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New hope for breast cancer patients with brain tumors: targeted drug shows promise
Disease control OngoingTUXEDO-4 is an international, multicentric, single arm, phase II study aiming to gather additional solid evidence of Trastuzumab-Deruxtecan (T-DXd) activity in patients with Human Epidermal Growth Factor Receptor 2 (HER2)-low breast cancer with active brain metastases. This stud…
Phase 2 • Sponsor: MedSIR • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New combo therapy aims to boost melanoma treatment
Disease control Recruiting nowThis is a phase 3, randomized, controlled study of brenetafusp (IMC-F106C) plus nivolumab compared to standard nivolumab regimens in HLA-A\*02:01-positive participants with previously untreated advanced melanoma.
Phase 3 • Sponsor: Immunocore Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Could a common ED drug and cycling help kids with duchenne?
Disease control Recruiting nowExamining two strategies as potential adjuvant therapies for Duchenne muscular dystrophy (DMD); aerobic exercise training (to induce adaptations in skeletal muscle and improve cardiovascular health) and tadalafil, an FDA-approved vasodilator (to optimize blood flow and muscle per…
Phase 2 • Sponsor: University of Florida • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Can sound waves calm both seizures and anxiety?
Symptom relief OngoingThe purpose of this study is to evaluate the feasibility, safety, and effects on anxiety of high intensity focused ultrasound ablation (FUSA) in patients suffering from treatment-refractory focal epilepsy and anxiety. FUSA is a non-invasive neurosurgical procedure that uses ultra…
Phase 1 • Sponsor: Ohio State University • Aim: Symptom relief
Last updated Jul 24, 2026 00:00 UTC
-
Mind and body rehab program aims to boost quality of life in heart disease survivors
Disease control Recruiting nowRemarkable progress in paediatric cardiology and surgery have led to the substantial increase of congenital heart disease (CHD) survivors. Long-term outcomes in rare and complex CHD have become a critical priority as three major sources of morbidity have been identified in this p…
Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Can a structured course help people at suicide risk build a personal safety plan?
Prevention Recruiting nowThe plan is to include patients with a history of increased risk of suicide. In the aftermath of an episode of imminent suicide risk, patients will receive a psychoeducational course that entails information on different aspects of suicide-related topics, identifying triggers and…
Sponsor: St. Olavs Hospital • Aim: Prevention
Last updated Jul 23, 2026 00:00 UTC
-
A prescription for play: can School-Based 'Green Prescriptions' revive teen activity?
Prevention CompletedThis study evaluated the effectiveness of the Green Prescription, a school-based behavioral intervention that incorporated health education, designed to increase physical activity among adolescents aged 15-17 years who were insufficiently active. Participants received individual…
Sponsor: Poznan University of Physical Education • Aim: Prevention
Last updated Aug 20, 2026 00:00 UTC
-
New trial aims to Fine-Tune prostate cancer treatment timing
Disease control Recruiting nowThis phase II trial studies the effects of stereotactic body radiation therapy (SBRT) and the timing of treatment with androgen receptor pathway inhibitor (ARPI) plus androgen deprivation therapy (ADT) in treating patients with hormone sensitive prostate cancer that has spread fr…
Phase 2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New TB detection methods could save thousands of lives in africa
Knowledge-focused Recruiting nowAs estimated by the WHO 10.6 million new Tuberculosis (TB) cases were identified in 2022- while more than three million went undetected and untreated. The low detection rate illustrates the failure to recognise and diagnose TB in the current cascade of healthcare and is a major o…
Sponsor: Aarhus University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC
-
New weekly shot could help teens with obesity and related health problems
Disease control Recruiting nowThe goal of the study is to assess how tirzepatide impacts bodyweight and cardiovascular risk factors when used in conjunction with healthy nutrition and physical activity in adolescents with obesity and multiple weight related comorbidities. The study will last approximately 76 …
Phase 3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
AI and PET scans could replace needle biopsies for prostate cancer grading
Diagnosis Recruiting nowProstate cancer is the most common type of cancer in Norwegian men, but many tumors are slow-growing and do not require treatment. Today, MRI is good at detecting suspicious lesions, yet it cannot reliably distinguish aggressive tumors from low-grade ones. As a result, many men u…
Sponsor: University Hospital of North Norway • Aim: Diagnosis
Last updated Jun 27, 2026 08:02 UTC
-
New study aims to tackle perinatal depression with coordinated care
Symptom relief Recruiting nowThe collaborative care model (CCM) is a health services intervention that integrates mental health care in primary care settings. The goal of this study is to adapt the CCM to the perinatal care context, including community co-designed adaptations to enhance health equity (COMPAS…
Sponsor: Women and Infants Hospital of Rhode Island • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
Ketamine showdown: which form works best for stubborn depression?
Symptom relief Recruiting nowThe goal of this study is to compare the effectiveness of two formulations of ketamine - Spravato® and racemic ketamine - in people with treatment-resistant depression (TRD). The main questions it aims to answer are: * How the two formulations compare in terms of their effective…
Phase 4 • Sponsor: The George Institute • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Eye drops could keep Kids' vision from getting worse
Disease control CompletedMyopia is one of the fastest-growing ocular disorders worldwide and has become a major public health concern, especially among children and adolescents. Progressive myopia is clinically significant because it increases the lifetime risk of serious ocular complications such as ret…
Phase 3 • Sponsor: Khyber Medical College, Peshawar • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Hope for myelofibrosis patients: new drug combo aims to shrink spleens and ease symptoms
Disease control Recruiting nowThis clinical trial is evaluating whether addition of navtemadlin to ruxolitinib treatment will provide more clinical benefit than ruxolitinib alone for patients with Myelofibrosis who have a suboptimal response to ruxolitinib treatment alone. Subjects will start by receiving ru…
Phase 3 • Sponsor: Kartos Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New hope for hodgkin lymphoma patients who Can't get transplants
Disease control Recruiting nowThe prognosis for patients with relapsed/refractory classical Hodgkin lymphoma (cHL) who refuse or are ineligible for transplant is poor. This open label, randomized, phase 2 study aims to evaluate the efficacy of Chidamide+Decitabine plus Anti-PD-1 Antibody and Brentuximab Vedot…
Phase 2 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC